by andyhopkinson | Aug 29, 2018 | News
Earlier this year, Dr Anna Malska from Elham Valley Referrals presented the work conducted at the practice by herself, Rebecca Elks and Barbara Gonella. The work involved using cross linking methods and Omnigen grafts to surgically repair severe melting ulcers. Anna...
by andyhopkinson | Aug 15, 2018 | News
NuVision are looking for Nottingham Trent University students to work with us during an internship and help us with the manufacturing of our product Omnigen and maintain our GMP laboratory. Please see below details of this: Manufacturing Technician internship...
by andyhopkinson | Aug 6, 2018 | News
NuVision® (www.nu-vision.co.uk) are delighted to announce that they have signed a distribution agreement with Doctrinemed (www.doctrinemed.com ), a Turkish pharmaceutical and medical device company with a focus on ophthalmology. Doctrinemed will be working closely...
by andyhopkinson | Jun 1, 2018 | News
Manufacturing Technician internship Start Date: 1/7/2018 Length of Internship: 3-4 months Salary: £1,200 per month Company: NuVision Biotherapies, Location: NuVision Biotherapies, MediCity D6 Building, Thane Road, Boots site, Nottingham, NG90 6BH Employer profile...
by andyhopkinson | Apr 16, 2018 | News
This year has so far consisted of a number of significant additions to the NuVision team. This month, we are delighted to announce the appointment of our new Sales and Marketing Director, Jonathan Hamill-Keays, who will lead and work alongside our new Territory...
by andyhopkinson | Mar 29, 2018 | News
NuVision Biotherapies is delighted to announce that Roger Teasdale has joined the Board as an Independent Non-Executive Director. Roger enjoyed a successful 25 year career at Smith & Nephew, the FTSE 100 Medical device business focused on the Advanced Wound...
by andyhopkinson | Mar 2, 2018 | News
NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel...
by andyhopkinson | Feb 15, 2018 | News
NuVision Biotherapies is delighted to announce the recent completion of a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will enable the company to increase sales both in the UK and to develop...
by andyhopkinson | Jan 10, 2018 | News
We are currently inviting applications for opportunities with the Commercial Specialist Team. We have opportunities on the following territories: Southern England London and East Anglia Midlands North England About NuVision Biotherapies This is your chance to join one...
by andyhopkinson | Oct 17, 2017 | News
NuVision Biotherapies Limited, a UK-based regenerative medicine company, and University of Tampere, Regea Cell and Tissue Centre, a Finnish clinical tissue bank, have announced the signing of a strategic partnership to distribute the sight saving and wound care...
